[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Jetema Co., Ltd.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":38},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":12,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":4},"100613377",false,"NCT07265791","Study of JTM104 Injection vs. Juvederm in Treating Moderate to Severe Nasolabial Folds","Multicenter, Randomized, Subject & Independent Evaluator-blind, Matched Pairs, Active-controlled, Non-inferiority, Pivotal Study to Evaluate the Efficacy and Safety of Injection With JTM104 as Compared to Juvederm® ULTRA PLUS XC in Temporary Correction of Moderate to Severe Nasolabial Folds","Inclusion Criteria:\n\n* Adults aged 19 to 75 years\n* Voluntarily provided written informed consent\n* Moderate to severe symmetrical nasolabial folds (WSRS score 3 or 4 on both sides)\n* Agree to discontinue other facial dermatologic treatments (e.g., fillers, botulinum toxin, laser) during the study\n* Able to understand instructions and comply with study procedures\n\nExclusion Criteria:\n\n* Untreated scars or facial skin infections\u002Fdiseases affecting the mid\u002Flower face within the past year\n* History of severe allergy or hypersensitivity to device components\n* Facial invasive procedures within the past 6 months (including surgery, laser, botulinum toxin)\n* Use of certain medications (anticoagulants, immunosuppressants, steroids) within specified washout periods\n* Participation in other interventional clinical trials within 4 weeks before screening or during study\n* Non-compliance with contraception requirements or pregnancy\u002Flactation during study\n* Deemed unsuitable by investigator for any other reason","ALL","19 Years","75 Years",{"count":19,"type":20},100,"ESTIMATED","INTERVENTIONAL",[23],"NA",[25],"Nasolabial Folds, Wrinkles","NOT_YET_RECRUITING","2025-11-24",{"date":29,"type":30},"2025-12-05","ACTUAL",{"date":32,"type":20},"2026-01-03",{"date":34,"type":20},"2027-01-31",{"name":36,"class":37},"Jetema Co., Ltd.","INDUSTRY",""]